Stock VICORE PHARMA HOLDING AB
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Vicore Pharma Holding AB Nasdaq Stockholm

Equities

End-of-day quote Nasdaq Stockholm
Other stock markets
- SEK - Intraday chart for Vicore Pharma Holding AB
05-22 Transcript : Vicore Pharma Holding AB - Special Call
05-20 Vicore Pharma Holding AB Announces Positive Final Results from the Phase 2a Air Trial Demonstrating Buloxibutid Improves Lung Function over 36 Weeks in Patients with Idiopathic Pulmonary Fibrosis CI

Chart calendar Vicore Pharma Holding AB

d4f0e13d298569932109af7.NsMXOMGTZunrzc_1W7QocdLaZiD5q22ikSDkM5-_UE8.b4hkZ6jAApm8griFI-djQ-OKHmSP5Qjz0k60YPndABhh9W5Rm-Ipu96A-w~c8cf08534d067fa07145042b5a8a2760

Upcoming events on Vicore Pharma Holding AB

21/08/2024 Q2 2024 Earnings Release
06/09/2024 European Respiratory Summit
04/11/2024 Q3 2024 Earnings Release
26/02/2025 Q4 2024 Earnings Release
30/04/2025 Q1 2025 Earnings Release (Projected)
20/08/2025 Q2 2025 Earnings Release (Projected)
29/10/2025 Q3 2025 Earnings Release (Projected)
25/02/2026 Q4 2025 Earnings Release (Projected)

Past events on Vicore Pharma Holding AB

22/05/2024 15:00 C21 Final Phase 2a AIR Trial Results Call
20/05/2024 19:30 American Thoracic Society Conference
20/05/2024 17:15 American Thoracic Society Conference
19/05/2024 18:39 American Thoracic Society Conference
16/05/2024 American Thoracic Society Conference
07/05/2024 13:00 Annual General Meeting
03/05/2024 07:20 Q1 2024 Earnings Release
17/04/2024 14:20 Kempen Life Sciences Conference
06/03/2024 17:50 TD Cowen Health Care Conference
06/03/2024 14:00 Carnegie Healthcare Conference
28/02/2024 07:00 Q4 2023 Earnings Release
13/02/2024 15:40 Oppenheimer Healthcare Life Sciences Conference
07/02/2024 19:30 Guggenheim Healthcare Talks Biotechnology Conference
28/11/2023 NLS Days
20/11/2023 SEB Healthcare Seminar
13/11/2023 Stifel Healthcare Conference
08/11/2023 PFF Summit
05/11/2023 Bio-Europe Conference
01/11/2023 Q3 2023 Earnings Release
18/09/2023 IPF Summit

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million SEK		Released
Forecast
Spread 		0,00
0,01
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
27,6
- 		0,00
0,01
-
52,0

EBITDA
Million SEK		Released
Forecast
Spread 		-92,7
-87,3
-6.19%		-150
-130
-14.66%		-291
-350
16.75%		-287
-318
9.58%		-256
-279
8.53%
-237

EBIT
Million SEK		Released
Forecast
Spread 		-94,0
-88,5
-6.29%		-150
-130
-14.69%		-295
-350
15.77%		-291
-318
8.44%		-322
-280
-14.7%
-238

Earnings before Tax (EBT)
Million SEK		Released
Forecast
Spread 		-93,3
-87,7
-6.45%		-147
-129
-14.25%		-297
-353
15.92%		-289
-311
7.01%		-311
-279
-11.48%
-237

Net income
Million SEK		Released
Forecast
Spread 		-93,1
-87,7
-6.17%		-147
-129
-14.14%		-297
-353
15.95%		-288
-310
7.05%		-311
-279
-11.38%
-236

EPS
SEK		Released
Forecast
Spread 		-2,16
-2,07
-4.4%		-2,71
-2,34
-15.79%		-4,25
-5,03
15.59%		-3,99
-3,89
-2.46%		-3,22
-2,58
-24.69%
-1,63

Announcement Date28/02/2026/02/2125/02/2228/02/2328/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q2 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales
Million SEK		Released
Forecast
Spread


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-


EBITDA
Million SEK		Released
Forecast
Spread 		-64,0


-65,2
-64,2
-1.54%		-69,0
-60,6
-13.86%		-64,2
-67,0
4.15%		-69,2
-67,1
-3.15%
EBIT
Million SEK		Released
Forecast
Spread 		-64,9


-66,1
-64,2
-2.98%		-69,8
-60,6
-15.25%		-65,1
-67,2
3.14%		-121
-67,1
-79.78%
Earnings before Tax (EBT)
Million SEK		Released
Forecast
Spread


-66,4
-63,7
-4.19%		-69,3
-59,9
-15.71%		-63,7
-66,3
3.97%		-112
-66,2
-69.09%
Net income
Million SEK		Released
Forecast
Spread 		-65,9


-66,3
-63,6
-4.22%		-69,2
-59,8
-15.73%		-63,6
-66,2
3.97%		-112
-66,1
-69.19%
EPS
SEK		Released
Forecast
Spread


-0,81
-0,78
-3.85%		-0,85
-0,73
-16.35%		-0,58
-0,65
11.16%		-1,00
-0,59
-68.94%
Announcement Date25/08/2204/05/2324/08/2302/11/2328/02/24

Upcoming sector events for Vicore Pharma Holding AB

23/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
24/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 06:00 ARGENX SE: Q2 2024 Earnings Release
29/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Vicore Pharma Holding AB

05/06/2024 08:51 PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
17/05/2024 12:00 AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 12:46 BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 06:00 ZEALAND PHARMA A/S: Q1 2024 Earnings Release
15/05/2024 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
15/05/2024 13:05 THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 12:00 CABALETTA BIO, INC.: Q1 2024 Earnings Release
14/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
14/05/2024 21:05 ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 21:00 ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. VICO Stock
  4. Stock
  5. Calendar Vicore Pharma Holding AB
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW